Getachew Aderaye

Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations

Eliford Ngaimisi, Abiy Habtewold, Omary Minzi et al. · PLoS ONE · 2013 · 124 citations · Full text

Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients

Getnet Yimer, Nobuhisa Ueda, Abiy Habtewold et al. · PLoS ONE · 2011 · 121 citations · Full text

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

Getnet Yimer, Wondwossen Amogne, Abiy Habtewold et al. · The Pharmacogenomics Journal · 2011 · 119 citations

Hepatology, Naïve Hiv Patients, Viral Hepatitis +8

Keratin‐18 and micro <scp>RNA</scp> ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts

Petra Thulin, Gunnar Nordahl, Marcus Gry et al. · Liver International · 2013 · 117 citations

Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia—an observational cohort study

Daniel Meressa, Rocio Hurtado, Jason R. Andrews et al. · Thorax · 2015 · 105 citations · Full text